{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"212"},{"groupId":"OG001","value":"226"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Mobility, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"47"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Mobility, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"30"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Mobility, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"11"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Mobility, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Mobility, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"149"},{"groupId":"OG001","value":"149"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Mobility, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"47"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Mobility, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"22"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Mobility, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"10"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Mobility, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Mobility, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"294"},{"groupId":"OG001","value":"284"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Self-care, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"22"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Self-care, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Self-care, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Self-care, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Self-care, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"198"},{"groupId":"OG001","value":"202"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Self-care, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"15"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Self-care, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Self-care, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Self-care, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Self-care, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"207"},{"groupId":"OG001","value":"208"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Usual Activities, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"64"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Usual Activities, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Usual Activities, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Usual Activities, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Usual Activities, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"133"},{"groupId":"OG001","value":"135"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Usual Activities, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"62"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Usual Activities, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"21"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Usual Activities, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Usual Activities, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Usual Activities, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"168"},{"groupId":"OG001","value":"161"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Pain/Discomfort, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"104"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Pain/Discomfort, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"40"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Pain/Discomfort, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Pain/Discomfort, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Pain/Discomfort, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"129"},{"groupId":"OG001","value":"124"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Pain/Discomfort, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"70"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Pain/Discomfort, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"23"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Pain/Discomfort, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Pain/Discomfort, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Pain/Discomfort, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"173"},{"groupId":"OG001","value":"177"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Anxiety/Depression, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"98"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Anxiety/Depression, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"30"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Anxiety/Depression, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Anxiety/Depression, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"315"},{"groupId":"OG001","value":"314"}],"units":"Participants"}],"title":"Baseline, Anxiety/Depression, Score 5"},{"categories":[{"measurements":[{"groupId":"OG000","value":"136"},{"groupId":"OG001","value":"126"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Anxiety/Depression, Score 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"74"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Anxiety/Depression, Score 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"24"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Anxiety/Depression, Score 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Anxiety/Depression, Score 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"228"},{"groupId":"OG001","value":"229"}],"units":"Participants"}],"title":"End of Treatment, Anxiety/Depression, Score 5"}],"denoms":[{"counts":[{"groupId":"OG000","value":"326"},{"groupId":"OG001","value":"328"}],"units":"Participants"}],"description":"The EQ-5D-5L contains a participant-reported score regarding health state measured on a visual analog scale (scores range from 0 \\[worst imaginable health state\\] to 100 \\[best imaginable health state\\]), and 5 questions on mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The 5 questions have 5 response levels: 1, no problems; 2, slight problems; 3, moderate problems; 4, severe problems; and 5, unable to/extreme problems.","groups":[{"description":"Participants with FL and MZL were randomized to receive tafasitamab 12 mg/kg IV, administered on Days 1, 8, 15, and 22 of Cycles 1 to 3 and on Days 1 and 15 of Cycles 4 to 12. Participants also received oral lenalidomide (including generics) 20 mg QD, administered at approximately the same time every day on Days 1 to 21 of Cycles 1 to 12, and rituximab (including biosimilars) 375 mg/m\\^2 IV, administered on Days 1, 8, 15, and 22 of Cycle 1 and on Day 1 of Cycles 2 to 5. A treatment cycle was defined as 28 calendar days.","id":"OG000","title":"FL and MZL: Tafasitamab + Rituximab + Lenalidomide"},{"description":"Participants with FL and MZL were randomized to receive placebo 0.9% saline solution IV, administered on Days 1, 8, 15, and 22 of Cycles 1 to 3 and on Days 1 and 15 of Cycles 4 to 12. Participants also received oral lenalidomide (including generics) 20 mg QD, administered at approximately the same time every day on Days 1 to 21 of Cycles 1 to 12, and rituximab (including biosimilars) 375 mg/m\\^2 IV, administered on Days 1, 8, 15, and 22 of Cycle 1 and on Day 1 of Cycles 2 to 5. A treatment cycle was defined as 28 calendar days.","id":"OG001","title":"FL and MZL: Placebo + Rituximab + Lenalidomide"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Overall Full Analysis Set. As pre-specified in the Statistical Analysis Plan, the MZL population was considered as a subpopulation of interest, not a main analysis population. The FL and MZL populations were combined for analysis into the Overall population, which was a main analysis population. Only participants with available data were analyzed.","reportingStatus":"POSTED","timeFrame":"up to approximately 34 months","title":"Overall Population: Number of Participants With the Indicated Scores for the Five EQ-5D-5L Domains/Questions at Baseline and End of Treatment","type":"SECONDARY","unitOfMeasure":"Participants"}